To The Moon

Sign Up

ARKG Investment Tracker

Source from：official website ARKG is an exchange-traded fund (ETF) managed by Cathie Wood, focusing on stocks related to the genomic revolution. The "ARK Genomic Revolution Fund Guru Tracker" is based on ARKG's daily disclosure reports, helping investors track its investment strategy.

    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Atai Beckley Inc by 11,826 shares, the number of shares held increased 0.36% compared to the previous period and now represents 1.12% of the total position.
      1Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Nurix Therapeutics by 33,696 shares, the number of shares held increased 2.21% compared to the previous period and now represents 2.2% of the total position.
      7Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Natera by 888 shares, the number of shares held increased 0.36% compared to the previous period and now represents 4.75% of the total position.
      1Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Veracyte by 3,933 shares, the number of shares held increased 0.36% compared to the previous period and now represents 3.84% of the total position.
      0Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Incyte by 486 shares, the number of shares held increased 0.36% compared to the previous period and now represents 1.09% of the total position.
      1Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in GeneDx Holdings by 31,827 shares, the number of shares held increased 21.46% compared to the previous period and now represents 2.23% of the total position.
      0Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Recursion Pharmaceuticals, Inc. by 41,721 shares, the number of shares held increased 0.36% compared to the previous period and now represents 4.3% of the total position.
      830Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Guardant Health Inc. by 2,499 shares, the number of shares held increased 0.36% compared to the previous period and now represents 5.57% of the total position.
      0Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Schrodinger Inc. by 6,828 shares, the number of shares held increased 0.36% compared to the previous period and now represents 2.63% of the total position.
      0Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Prime Medicine, Inc. by 17,868 shares, the number of shares held increased 0.36% compared to the previous period and now represents 1.46% of the total position.
      26Comment
      Report
       
       
       
       

      Most Discussed